The Role of the Journal of Psychedelic Drugs in the Evolution of Psychedelic Medicine.
Journal of psychoactive drugs January 1, 2019 DOI: 10.1080/02791072.2019.1589607 via PubMed
Summary
AI-generated from the abstractThis review describes the central role that this journal, and its founder Dr. David Smith, has played in documenting the second wave of psychedelic research. As modern culture enters a third wave of the psychedelic revival, the journal has witnessed and supported research exploring the therapeutic uses of psychedelics. The article traces this historical trajectory, highlighting how the journal has served as a key platform for scholarship on psychedelic medicine and therapy across these eras.
Study at a glance
| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Topics | LSD |
| Keywords | History Journal Psychedelic Third wave |
| Citations | 3 |
| Key finding | The journal and Dr. David Smith have been primary witnesses to the second wave of psychedelic research and continue to play a role as the third wave of psychedelic revival explores therapeutic uses. |
Abstract
A review of the primary role that this journal (and by extension, Dr. David Smith) has played in bearing witness to the second wave of psychedelic research as our modern-day culture embraces the current third wave of the psychedelic revival, exploring through research its therapeutic uses.